Clinical Trial Update: Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting Stents [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing short versus 12 months of prasugrel plus aspirin in acute coronary syndrome patients treated with percutaneous coronary interve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Aspirin (Aspirin)
• PRASUGREL (prasugrel)

Snippet

Sponsor: Odense University Hospital | Conditions: Acute Coronary Syndrome | Phase 4 | Status: RECRUITING